Patents/Assignees

Janssen Sciences Ireland Unlimited Company

13 patents in portfolio

US12275770utility2025
Glucagon Like Peptide 1 (glp1)-growth Differentiation Factor 15 (GDF15) Fusion Proteins and Uses Thereof
0 cites
US12178815utility2024
Regimens for Treating HIV Infections and Aids
0 cites
US12145933utility2024
Hemi (l)-tartrate Forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1 H -indol-2-yl}methyl)-1-(2,2,2-trifluoroethy)-1,3-dihydro-2 H -imidazo[4,5-c]pyridin-2-one and Pharmaceutical Compositions Comprising the Same
0 cites
USRE050189reissue2024
Long Term Treatment of Hiv-infection with TMC278
0 cites
US11918575utility2024
PZA and Cytochrome Bc1 Inhibitor Combination Treatment
0 cites
US11866419utility2024
Antibacterial Compounds
0 cites
US11780900utility2023
Glucagon Like Peptide 1 (GLP-1) Fusion Peptide Coupled Cyclic Peptide Tyrosine Tyrosine Conjugates and Uses Thereof
0 cites
US11725194utility2023
Hepatitis B Virus (HBV) Vaccines and Uses Thereof
0 cites
US11713345utility2023
Glucagon Like Peptide 1 (glp1)-growth Differentiation Factor 15 (GDF15) Fusion Proteins and Uses Thereof
0 cites
US11708369utility2023
Heteroaromatic Compounds Having Activity Against RSV
0 cites
US11702426utility2023
Macrocyclic Deaza-purinones for the Treatment of Viral Infections
0 cites
US11597704utility2023
2,4-diaminoquinazoline Derivatives and Medical Uses Thereof
0 cites
US11564921utility2023
Regimens for Treating HIV Infections and AIDS
0 cites